Effects of short- and long-acting beta-agonists on asthma exacerbations: a prospective cohort

医学 哮喘 吸入性皮质类固醇 B2受体 前瞻性队列研究 儿科 内科学 队列 队列研究 物理疗法 缓激肽 受体
作者
Eric H. Van Ganse,Nathalie Texier,Alexandra Lelia Dima,Manon Belhassen,Laurent Laforest,Sandrine Herbage,Stéphane Schück,Gimena Hernández,Olatz Garín,Montse Ferrer,Marijn de Bruin
出处
期刊:Annals of Allergy Asthma & Immunology [Elsevier BV]
卷期号:124 (3): 254-260 被引量:14
标识
DOI:10.1016/j.anai.2019.12.012
摘要

BACKGROUND: In asthma, short- and long-acting β-agonists (SABAs and LABAs) should be used together with inhaled corticosteroids (ICS), and regular use is inappropriate. OBJECTIVE: To assess the relationship between patterns of use of therapy and asthma exacerbations (AEx). METHODS: Patients with asthma (6-40 years) were enrolled in France and the United Kingdom. Prescribing data, computer-assisted telephone interviews (CATIs), and text messages assessed medication use and AEx over a maximum period of 24 months. Generalized linear mixed models provided AEx risks associated with therapy. RESULTS: Among the 908 patients (median age: 20.0 years, 46.6% women, 24.5% children) answering a total of 4248 CATIs over 486 (±235) days, regular (ie, daily) use was more frequent for single LABAs and fixed dose combinations (FDCs) than for single ICS (75.6%, 70.1%, and 65.4% of investigated periods of use, respectively). Regular (ie, daily or almost daily) SABA use was observed for 21.1% of periods of use. Altogether, 265 patients (29.2%) experienced 1 or more AEx. The ORs for AEx risk related to regular vs no use of FDCs, single ICS, and single LABAs were 0.98 (95% CI = [0.73-1.33]), 0.90 (95% CI = [0.61-1.33]), and 1.29 (95% CI = [0.76-2.17]), respectively, after adjustment for cotherapy, sociodemographic, and disease characteristics. The OR was 2.09 (95% CI = [1.36-3.21]) in regular SABA users. CONCLUSION: Inhaled corticosteroids and FDCs were often used intermittently, whereas SABAs and LABAs could be used regularly, and exacerbations were frequent. Compared with non-users, the risk of exacerbation increased moderately under regular use of single LABAs, whereas it doubled, significantly, in regular SABA users, likely in relationship with poor overall asthma control.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
butterflycat完成签到,获得积分10
1秒前
1秒前
1秒前
2秒前
旺仔完成签到,获得积分10
2秒前
wxxd完成签到,获得积分10
2秒前
哈哈哈发布了新的文献求助10
2秒前
趁热拿铁完成签到 ,获得积分10
3秒前
3秒前
4秒前
还单身的蜻蜓完成签到,获得积分10
4秒前
qingsi完成签到 ,获得积分10
4秒前
5秒前
666发布了新的文献求助10
5秒前
郭娅楠发布了新的文献求助10
5秒前
6秒前
所所的应助被枕文观汐采纳,获得10
6秒前
淡定自中完成签到,获得积分10
6秒前
Yiphy发布了新的文献求助10
7秒前
FashionBoy的应助被lirongcas采纳,获得10
7秒前
意忆完成签到,获得积分10
9秒前
11发布了新的文献求助10
9秒前
ALWAYS完成签到,获得积分10
10秒前
可靠巧曼完成签到,获得积分20
10秒前
希望天下0贩的0的应助被薇子采纳,获得10
10秒前
Hello的应助被墨羽采纳,获得10
11秒前
鲤鱼绣连发布了新的文献求助10
11秒前
哈哈哈发布了新的文献求助10
11秒前
syvshc的应助被慎独采纳,获得10
12秒前
12秒前
13秒前
syvshc的应助被嘉的科研采纳,获得10
13秒前
ee完成签到 ,获得积分10
13秒前
14秒前
14秒前
15秒前
15秒前
kll完成签到,获得积分10
15秒前
黎明完成签到,获得积分10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8186012
求助须知:如何正确求助?哪些是违规求助? 9574616
关于积分的说明 21837084
捐赠科研通 7783730
什么是DOI,文献DOI怎么找? 3434729
关于科研通互助平台的介绍 2559055
邀请新用户注册赠送积分活动 2481504